Envista (NYSE:NVST) Upgraded to “Strong-Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Envista (NYSE:NVST) from a buy rating to a strong-buy rating in a research note published on Saturday morning.

A number of other equities research analysts also recently weighed in on the stock. Evercore ISI reiterated an “outperform” rating on shares of Envista in a research report on Friday, October 31st. Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, September 15th. Stifel Nicolaus set a $25.00 target price on Envista in a research report on Thursday, October 30th. Mizuho set a $19.00 target price on Envista in a report on Monday, November 3rd. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $21.77.

Envista Stock Up 0.0%

Shares of NVST opened at $23.62 on Friday. The firm has a market cap of $3.88 billion, a P/E ratio of 262.52, a price-to-earnings-growth ratio of 1.05 and a beta of 0.99. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37. Envista has a 52 week low of $14.22 and a 52 week high of $23.97. The firm’s 50-day simple moving average is $21.06 and its 200 day simple moving average is $20.63.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, October 29th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. The company had revenue of $669.90 million for the quarter, compared to the consensus estimate of $639.49 million. Envista had a return on equity of 5.90% and a net margin of 0.58%.The firm’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.12 earnings per share. On average, analysts forecast that Envista will post 1 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of NVST. Farther Finance Advisors LLC lifted its stake in shares of Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after acquiring an additional 1,026 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after purchasing an additional 949 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after purchasing an additional 1,909 shares in the last quarter. Finally, SJS Investment Consulting Inc. grew its position in shares of Envista by 10,356.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock valued at $49,000 after buying an additional 2,382 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.